New: NCI-funded clinical trial search
Mednet Logo
SpecialtiesRheumatology
Rheumatology

Rheumatology

Clinical discussions on autoimmune diseases, biologic therapies, vasculitis, and musculoskeletal conditions.

Recent Discussions

What is the recommended fungal workup in an immunocompromised patient after 5 days of persistent fever?

1
4 Answers

Mednet Member
Mednet Member
Infectious Disease · University of Texas Southwestern Medical School

For any patient with fevers, I focus significantly on any symptoms that a patient might have, like headache, diarrhea, and sinus symptoms, and work up a differential diagnosis based on possible pathogens in this area. If I am not finding anything, I would obtain a CT chest/abd/pelvis, as both invasi...

How has the ADVISE trial changed your approach to steroid sparing agents for non-infectious uveitis?

2
2 Answers

Mednet Member
Mednet Member
Rheumatology · Legacy Devers Eye Institute

The ADVISE trial was a well-designed, multinational trial that compared adalimumab therapy for non-infectious intermediate, posterior, or panuveitis versus conventional immunosuppressive therapy or CID. Two hundred twenty-seven subjects were enrolled over four years, and a fifth year was required to...

Would you start urate lowering therapy in a patient with recurrent flares of joint pain/swelling and urate deposition confirmed by dual energy CT, despite a serum uric acid of 5 mg/dL between flares?

1 Answers

Mednet Member
Mednet Member
Rheumatology · University of Kansas

Of course, with colchicine or NSAID co-prescription, but first examine dietary excesses and medication effects, which can produce flares.

Can sIL2-R differentiate between active sarcoidosis affecting small airways vs uncontrolled asthma and guide treatment with methotrexte vs biologics?

2 Answers

Mednet Member
Mednet Member
Pulmonology · Mayo Clinic

Not exactly, and probably not with enough compelling precision to use it clinically. sIL-2R cannot reliably differentiate active small-airway sarcoidosis from uncontrolled asthma, nor can it independently select methotrexate versus biologic therapy. It is a marker of systemic T-lymphocyte/granuloma ...

How do you approach management autoimmune lymphoproliferative syndrome (ALPS) complicated by HLH?

2 Answers

Mednet Member
Mednet Member
Rheumatology · Baptist Health Jacksonville Rheumatology

Excellent and tough question. There are no direct guidelines for this specific question. We will have to extrapolate from other evidence and clinical reasoning.Investigation of the trigger must occur in parallel with management. I will discuss how I approach investigation first and then management.I...

What strategies have you found most helpful to improve adherence to hydroxychloroquine among patients with lupus?

1
3 Answers

Mednet Member
Mednet Member
Rheumatology · University of Alabama Birmingham

In my practice, three approaches have been most useful: Make adherence measurable. I routinely check whole-blood hydroxychloroquine levels and review the trend with patients in a nonjudgmental way. This creates accountability and turns an otherwise “invisible” treatment into something concrete that ...

For patients with patellofemoral pain syndrome whose symptoms continue despite an adequate course of physical therapy, what adjunctive treatments (bracing, taping, injections, orthotics, or imaging) do you consider most helpful?

1 Answers

Mednet Member
Mednet Member
Primary Care · Wake Forest University

After an adequate course of physical therapy (under the guidance of a knowledgeable PT), I recommend imaging to determine if there is underlying pathology like chondromalacia, chondrosis/fissuring, an OCD lesion, or perhaps a tendinopathy or fat pad impingement. Starting with a plain film (AP, later...

How often do you draw screening ANAs for discoid lupus?

2 Answers

Mednet Member
Mednet Member
Rheumatology · Harvard Medical School

Because a positive ANA is associated with an increased risk of progression to SLE in patients with discoid lupus, I routinely check an ANA at the initial visit in virtually all patients. If negative, I repeat it only if new symptoms concerning systemic involvement arise (e.g., joint pain, cytopenias...

How do you counsel patients with GCA on the benefits of steroids who have already experienced vision loss?

4
5 Answers

Mednet Member
Mednet Member
Neurology · The University of Iowa

I first tell the patient they are at considerable risk for further visual loss in the same eye or the other eye over the next 1-2 weeks. I also let them know that, even though their risk of visual loss has been reduced, their best option for preventing further visual loss is immediately starting hig...

Under what circumstances would you consider low-dose radiation therapy for osteoarthritis in an older adult patient?

2
3 Answers

Mednet Member
Mednet Member
Rheumatology · Duke University Medical Center

Here is a recent expert consensus by Joel Block on the use of low-dose radiation therapy in OA: Some highlights: "Placebo-controlled randomized clinical trials have now been reported using LDRT for OA of the knees and of the hands. Taken together, they do not show benefit beyond placebo... While a d...